These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Persistence of antibody in adolescents and adults after a third, booster, dose of poliomyelities vaccine. KENDALL EJ, BESWICK TS, MILLER A, TOBIN JO. Br Med J; 1960 Jun 04; 1(5187):1689-91. PubMed ID: 14408469 [No Abstract] [Full Text] [Related]
10. [Observations on the antibody and protein pictures in acute anterior poliomyelitis]. CASSANO A, MARINONI GF, RIZZA O, NUZZOLO L, GIORDANO G, RAVETTA M. Boll Soc Ital Biol Sper; 1960 Feb 29; 36():173-4. PubMed ID: 13808200 [No Abstract] [Full Text] [Related]
15. Estimate of molecular equivalents of antibody required for prophylaxis and therapy of poliomyelitis. STEVENS KM. J Hyg (Lond); 1959 Jun 29; 57(2):198-201. PubMed ID: 13664987 [No Abstract] [Full Text] [Related]
18. [The formation of neutralizing antibodies in humans after poliomyelitis immunization with the Behring vaccine]. KELLER W, SAUTHOFF R. Dtsch Med Wochenschr; 1955 Sep 16; 80(37):1329-31. PubMed ID: 13261706 [No Abstract] [Full Text] [Related]
19. [Study of poliomyelitis antibodies in Lorraine before, during and after vaccination with the Lepine vaccine in a group of subjects observed systematically]. de LAVERGNE, GERBAUT P, LORRAIN J, POLJE F, GILGENKRANTZ, LE MOYNE MT, MATHIEU J. Ann Inst Pasteur (Paris); 1959 Dec 16; 97():848-54. PubMed ID: 14414644 [No Abstract] [Full Text] [Related]